Ionizing radiation expands a p90RSK-activated patrolling monocyte subset: modulation by colchicine.

Saved in:
Bibliographic Details
Title: Ionizing radiation expands a p90RSK-activated patrolling monocyte subset: modulation by colchicine.
Authors: Imanishi M; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Samanthapudi VSK; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Le NT; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States., Rivera LA; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kim JH; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Instituto Tecnológico y de Estudios Superiores de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Nuevo León, México., Lee J; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Pediatric Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mejia GF; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hoang O; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Deswal A; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Schadler KL; Department of Pediatric Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hildebrandt MAT; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Yusuf SW; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wang G; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, United States., Burks JK; Department of Leukemia, Division of Center Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Nurieva RI; Department of Leukemia, Division of Discovery Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Palaskas NL; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Nead KT; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Amir ED; Astrolabe Diagnostics, Inc., Fort Lee, NJ, United States., Koutroumpakis E; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lin SH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States, United States., Abe JI; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kotla S; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Source: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2026 Apr 15; Vol. 13, pp. 1763490. Date of Electronic Publication: 2026 Apr 15 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2297-055X
DOI:10.3389/fcvm.2026.1763490